Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Sirukumab (Anti-IL-6 / IFNb2) For research use only.
Not for use in humans.

Sirukumab (Anti-IL-6 / IFNb2)

Synonyms: CNTO-136

Sirukumab (Anti-IL-6 / IFNb2) is a humanized monoclonal IgG1κ antibody targeting IL6 (Interleukin Related). It has the potential for active lupus nephritis research. MW :144.58 KD.

Sirukumab (Anti-IL-6 / IFNb2)

Purity & Quality Control

Batch: A298001 Purity: 99% Protein concentration: 5.32mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Sirukumab (Anti-IL-6 / IFNb2) is a humanized monoclonal IgG1κ antibody targeting IL6 (Interleukin Related). It has the potential for active lupus nephritis research. MW :144.58 KD.

Product Details

CAS No. 1194585-53-9
Molecular Weight 144.58
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Sirukumab (Anti-IL-6 / IFNb2) | Sirukumab (Anti-IL-6 / IFNb2) supplier | purchase Sirukumab (Anti-IL-6 / IFNb2) | Sirukumab (Anti-IL-6 / IFNb2) cost | Sirukumab (Anti-IL-6 / IFNb2) manufacturer | order Sirukumab (Anti-IL-6 / IFNb2) | Sirukumab (Anti-IL-6 / IFNb2) distributor